<?xml version='1.0' encoding='utf-8'?>
<document id="26079264"><sentence text="Rapid quantitative analysis of ormeloxifene and its active metabolite, 7-desmethyl ormeloxifene, in rat plasma using liquid chromatography-tandem mass spectrometry."><entity charOffset="31-43" id="DDI-PubMed.26079264.s1.e0" text="ormeloxifene" /><entity charOffset="71-95" id="DDI-PubMed.26079264.s1.e1" text="7-desmethyl ormeloxifene" /><pair ddi="false" e1="DDI-PubMed.26079264.s1.e0" e2="DDI-PubMed.26079264.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26079264.s1.e0" e2="DDI-PubMed.26079264.s1.e1" /></sentence><sentence text="Ormeloxifene (ORM) is a non-steroidal, selective estrogen receptor modulator used as a once a week oral contraceptive and is intended for long-term clinical use by females"><entity charOffset="0-12" id="DDI-PubMed.26079264.s2.e0" text="Ormeloxifene" /><entity charOffset="14-17" id="DDI-PubMed.26079264.s2.e1" text="ORM" /><entity charOffset="49-57" id="DDI-PubMed.26079264.s2.e2" text="estrogen" /><pair ddi="false" e1="DDI-PubMed.26079264.s2.e0" e2="DDI-PubMed.26079264.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26079264.s2.e0" e2="DDI-PubMed.26079264.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26079264.s2.e0" e2="DDI-PubMed.26079264.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26079264.s2.e1" e2="DDI-PubMed.26079264.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26079264.s2.e1" e2="DDI-PubMed.26079264.s2.e2" /></sentence><sentence text=" Therefore, a simple, sensitive and rapid LC-MS/MS method was developed and validated for simultaneous quantification of ORM and its active metabolite (7-desmethyl ormeloxifene, 7-DMO) in rat plasma"><entity charOffset="178-183" id="DDI-PubMed.26079264.s3.e0" text="7-DMO" /><entity charOffset="121-125" id="DDI-PubMed.26079264.s3.e1" text="ORM" /><pair ddi="false" e1="DDI-PubMed.26079264.s3.e1" e2="DDI-PubMed.26079264.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26079264.s3.e1" e2="DDI-PubMed.26079264.s3.e0" /></sentence><sentence text=" Also, the method was partially validated in human plasma" /><sentence text=" Chromatographic separation was achieved on Discovery HS C-18 column (5μm, 50×4" /><sentence text="6mm) with mobile phase [acetonitrile: aqueous ammonium acetate (0"><entity charOffset="23-36" id="DDI-PubMed.26079264.s6.e0" text="[acetonitrile" /><entity charOffset="46-62" id="DDI-PubMed.26079264.s6.e1" text="ammonium acetate" /><pair ddi="false" e1="DDI-PubMed.26079264.s6.e0" e2="DDI-PubMed.26079264.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26079264.s6.e0" e2="DDI-PubMed.26079264.s6.e1" /></sentence><sentence text="01M) buffer (85: 15, %v/v)] at a flow rate of 0" /><sentence text="8mL/min" /><sentence text=" The calibration curve was linear (r≥0" /><sentence text="99) for a concentration range of 0" /><sentence text="78-100ng/mL for both the analytes" /><sentence text=" The precision (%RSD; ORM, 1"><entity charOffset="22-37" id="DDI-PubMed.26079264.s12.e0" text="ORM" /></sentence><sentence text="3 to 13" /><sentence text="4; 7-DMO, 3"><entity charOffset="3-5" id="DDI-PubMed.26079264.s14.e0" text="7-DMO" /></sentence><sentence text="1 to 15" /><sentence text="0) and accuracy (%bias; ORM, -13"><entity charOffset="24-27" id="DDI-PubMed.26079264.s16.e0" text="ORM" /></sentence><sentence text="8 to 12" /><sentence text="5; 7-DMO, -10"><entity charOffset="3-5" id="DDI-PubMed.26079264.s18.e0" text="7-DMO" /></sentence><sentence text="6 to 6" /><sentence text="8) in both rat and human plasma were within the acceptable limits" /><sentence text=" The recovery for ORM and 7-DMO was always &gt;79"><entity charOffset="26-31" id="DDI-PubMed.26079264.s21.e0" text="7-DMO" /><entity charOffset="18-22" id="DDI-PubMed.26079264.s21.e1" text="ORM" /><pair ddi="false" e1="DDI-PubMed.26079264.s21.e1" e2="DDI-PubMed.26079264.s21.e1" /><pair ddi="false" e1="DDI-PubMed.26079264.s21.e1" e2="DDI-PubMed.26079264.s21.e0" /></sentence><sentence text="1% and &gt;72" /><sentence text="9%, respectively" /><sentence text=" Both the analytes were found stable in rat plasma even after 30 days of storage at -80°C and on being subjected to three freeze-thaw cycles" /><sentence text=" The method has not only short run time (3" /><sentence text="5min) but requires a low plasma sample volume (20μL) and is the first reported LC-MS/MS method for simultaneous quantification of the marketed drug known as centchroman (INN: ormeloxifene) and the metabolite 7-DMO in plasma"><entity charOffset="175-187" id="DDI-PubMed.26079264.s26.e0" text="ormeloxifene" /><entity charOffset="208-213" id="DDI-PubMed.26079264.s26.e1" text="7-DMO" /><pair ddi="false" e1="DDI-PubMed.26079264.s26.e0" e2="DDI-PubMed.26079264.s26.e0" /><pair ddi="false" e1="DDI-PubMed.26079264.s26.e0" e2="DDI-PubMed.26079264.s26.e1" /></sentence><sentence text=" The method was applied to evaluate drug-drug interaction of ORM with the commonly prescribed antidepressant drug sertraline using serial sampling in rats"><entity charOffset="61-65" id="DDI-PubMed.26079264.s27.e0" text="ORM" /></sentence><sentence text=" " /></document>